# Janaki (NMI) Nadarajah DPM – FDA Inspection, Mar 7, 2024

Source: https://www.keypedia.com/records/fda_inspections/janaki-nmi-nadarajah-dpm/304a10e6-2229-484a-95c5-59c1dae760b0
Source feed: FDA_Inspections

> FDA inspection 1234038 of Janaki (NMI) Nadarajah DPM, March 07, 2024. 3 citations under 21 CFR part 312. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1234038
- Company Name: Janaki (NMI) Nadarajah DPM
- Inspection Date: 2024-03-07
- Project Area: Bioresearch Monitoring
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Atlanta District Office
- Citation Count: 3

## Related Documents

- [FDA Inspection 962330 - 2016-02-04](https://www.keypedia.com/records/fda_inspections/janaki-nmi-nadarajah-dpm/a3a986db-1476-4f42-b7bd-2e79467d4a45)

## Related Officers

- [Investigator](https://www.keypedia.com/people/deborah-a-greco/38e393b5-55c4-461c-a0b0-4937e0cbec37)

Company: https://www.keypedia.com/companies/janaki-nmi-nadarajah-dpm/8ee4d7ba-ccbd-4b6e-a559-07be0d00219a

Office: https://www.keypedia.com/offices/atlanta-district-office/7586d99a-288e-49d1-8c3d-d88b7354b7a7